全球數位病理學的成長機會

遠端病理學中的人工智慧增加了遠距離診斷和協作模型的潛力

隨著人們對精準醫療的興趣日益濃厚，以及醫院和實驗室對遠端醫療和數位解決方案的需求不斷成長，數位病理學有機會在臨床、製藥和研究應用中發展。

基於人工智慧的演算法以及資料管理和分析軟體的進步為改進工作流程、自動化繁瑣的任務以及更好地利用所有領域的工作空間提供了巨大的潛力。

該報告研究了數位病理學市場並提供了 2022 年至 2027 年的預測。我們將數位病理學定義為為管理和解釋整個組織病理學幻燈片提供數位環境的系統、應用程式和服務。該分析提供了有關市場集中度和演變、主要數位病理解決方案提供者、應用領域和認證的資訊。這項研究幫助供應商了解世界各地區在不同應用領域發生的重要趨勢。

數位病理市場頂部整合，底部高度分散。在整個價值鏈中，大公司的地位突出，並透過併購發展起來。

該研究對北美、歐洲和亞太地區的數位病理學細分市場（硬體、軟體和服務）進行了深入分析，重點關注預測期內的新興商業模式和成長機會。

目錄

戰略衝動

• 為什麼成長如此困難？
• The Strategic Imperative 8（TM）
• 關鍵策略激勵措施對數位病理產業的影響
• 成長機會推動Growth Pipeline Engine（TM）

成長機會分析

• 分析範圍
• 按產品細分
• 按地區細分
• 主要競爭
• 成長指標
• 數位病理工作流程
• 數位病理解決方案銷售管道
• 生長促進因子
• 成長抑制因素
• 預測假設
• 收益預測
• 收益預測（按產品）
• 按產品分類的收益比率預測
• 按地區分類的收益預測
• 按地區分類的收益比率預測
• 收益預測分析
• 行業現狀 - 地理亮點
• 價格趨勢和預測分析
• 競爭環境
• 收益佔有率
• 收益佔有率分析
• 按供應商類型分類的數位病理學生態系統
• 特色企業
• 企業解決方案
• 著名的夥伴關係和合作
• 合作夥伴類型和機會
• 商業模式概述
• 按業務模式分類的解決方案採用曲線
• 數位病理學中的人工智慧
• 採用基於人工智慧的數位病理技術
• 數位病理學中的人工智慧 - 當前和未來的應用
• 創業投資/私募股權資金籌措

成長機會分析：硬體

• 成長指標
• 收益預測
• 按地區分類的收益預測
• 預測分析

成長機會分析：軟體

• 成長指標
• 收益預測
• 按地區分類的收益預測
• 預測分析

成長機會分析：服務

• 成長指標
• 收益預測
• 按地區分類的收益預測
• 預測分析

成長機會分析：北美

• 市場動態-北美數位病理市場
• 成長指標
• 收益預測
• 收益預測（按產品）
• 預測分析

成長機會分析：歐洲

• 市場動態- 歐洲數位病理市場
• 成長指標
• 收益預測
• 收益預測（按產品）
• 預測分析

成長機會分析：亞太地區

• 市場動態-亞太數位病理市場
• 成長指標
• 收益預測
• 收益預測（按產品）
• 預測分析

法規情勢分析

• 法規現況 -美國數位病理市場
• FDA WSI 器材評估的上市前申請要求
• 端到端解決方案的法規里程碑
• FDA核准/510(k) 透明產品
• 美國新的數位病理學附加代碼
• 法規現況 - 歐洲數位病理市場
• CE標誌產品

成長機會宇宙

• 成長機會1：亞太地區新興市場的擴張
• 成長機會2：協力網路與資料共用平台
• 成長機會 3：影像微陣列 (IMA)整合
• 成長機會 4：整合診斷與企業影像工作流程

下一步

AI in Telepathology Enhancing Potential for Remote Diagnosis and Collaborative Models

With increased interest in precision medicine and demand for telemedicine and digital solutions in hospitals and laboratories, digital pathology has the opportunity to grow in its clinical, pharma, and research applications.

Advances in AI-based algorithms and data management and analysis software offer immense potential in improving workflow, automating tedious tasks, and making better use of workspaces in all areas of the industry.

The report examines the digital pathology market and provides a forecast from 2022 to 2027. Frost & Sullivan defines digital pathology as systems, applications, and services that offer a digital environment for managing and interpreting whole slides for histopathology. The analysis provides information on market concentration and evolution, the leading digital pathology solutions providers, application areas, and certifications. This study will help vendors understand critical trends emerging for various application domains in each region globally.

The digital pathology market is consolidated at the top and highly fragmented at the bottom, with many small players offering focused solutions. Large companies have a prominent presence across the value chain, which they have developed through mergers and acquisitions.

The global study provides a detailed analysis of digital pathology market segments (hardware, software, and services) in North America, Europe, and Asia-Pacific, highlighting emerging business models and growth opportunities over the forecast period.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Digital Pathology Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of Analysis
• Segmentation by Product
• Segmentation by Region
• Key Competitors
• Growth Metrics
• Digital Pathology Workflow
• Distribution Channels for Digital Pathology Solutions
• Growth Drivers
• Growth Restraints
• Forecast Assumptions
• Revenue Forecast
• Revenue Forecast by Product
• Percent Revenue Forecast by Product
• Revenue Forecast by Region
• Percent Revenue Forecast by Region
• Revenue Forecast Analysis
• State of the Industry-Geographical Highlights
• Pricing Trends and Forecast Analysis
• Competitive Environment
• Revenue Share
• Revenue Share Analysis
• Digital Pathology Ecosystem by Vendor Type
• Companies to Watch
• Company Solutions
• Notable Partnerships and Collaborations
• Types of Partnership and Opportunities
• Business Models Overview
• Solution Adoption Curve by Business Model
• AI in Digital Pathology
• AI-based Digital Pathology Technology Adoption
• AI in Digital Pathology-Current and Future Applications
• Venture Capital/Private Equity Funding

Growth Opportunity Analysis: Hardware

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: Software

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: Services

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: North America

• Market Dynamics-NA Digital Pathology Market
• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Product
• Forecast Analysis

Growth Opportunity Analysis: Europe

• Market Dynamics-Europe Digital Pathology Market
• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Product
• Forecast Analysis

Growth Opportunity Analysis: Asia-Pacific

• Market Dynamics-APAC Digital Pathology Market
• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Product
• Forecast Analysis

Regulatory Landscape Analysis

• Regulatory Landscape-US Digital Pathology Market
• Pre-market Application Requirements for FDA Evaluation of a WSI Device
• Regulatory Landmarks for End-to-end Solutions
• FDA-Approved/510(k)-cleared Products
• New Digital Pathology Add-on Codes in the United States
• Regulatory Landscape-Europe Digital Pathology Market
• CE-marked Products

Growth Opportunity Universe

• Growth Opportunity 1: Expansion in APAC Emerging Markets
• Growth Opportunity 2: Collaborative Networks and Data Sharing Platforms
• Growth Opportunity 3: Integration of Image Microarrays (IMAs)
• Growth Opportunity 4: Integrated Diagnosis and Enterprise Imaging Workflows

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer